NEW HAVEN, Conn., Feb. 5, 2009 (GLOBE NEWSWIRE) -- Achillion Pharmaceuticals, Inc. (NASDAQ: ACHN), a leader in the discovery and development of small molecule drugs to combat the most challenging infectious diseases, today announced that Michael Kishbauch, President and Chief Executive Officer, will give a corporate presentation at the upcoming 11th Annual BIO CEO & Investor Conference on Monday, February 9, 2009 at 12.00 p.m. EST at the Waldorf-Astoria Hotel in New York City.
